Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NVCR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Christoph Brackmann Chief Financial Officer | NVCR NovoCure Limited | Sale | 7,343 | $12.86 | $94.4K Sale | Form 4 ↗ |
| Nov 9, 2026 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 3,079 | $12.86 | $39.6K Sale | Form 4 ↗ |
| Nov 2, 2026 | Michal Nath Puri Chief Human Resources Officer | NVCR NovoCure Limited | Sale | 660 | $13.24 | $8,738 Sale | Form 4 ↗ |
| Jun 4, 2026 | Frank X. Leonard Chief Executive Officer | NVCR NovoCure Limited | Sale | 34,273 | $17.93 | $614.5K Sale | Form 4 ↗ |
| Jun 2, 2026 | Kristin Stafford Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | Ocean Allyson J Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | Timothy J. Scannell Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | W. Anthony Vernon Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | David Hung Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | Gabriel Leung Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Jun 2, 2026 | Jeryl L. Hilleman Director | NVCR NovoCure Limited | Sale | 2,945 | $15.77 | $46.4K Sale | Form 4 ↗ |
| Mar 5, 2026 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 43,246 | $13.77 | $595.5K Sale | Form 4 ↗ |
| Mar 4, 2026 | Christoph Brackmann Chief Financial Officer | NVCR NovoCure Limited | Sale | 6,412 | $13.31 | $85.3K Sale | Form 4 ↗ |
| Mar 4, 2026 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 5,377 | $13.31 | $71.6K Sale | Form 4 ↗ |
| Mar 4, 2026 | Nicolas Leupin Former Chief Medical Officer | NVCR NovoCure Limited | Sale | 1,100 | $13.31 | $14.6K Sale | Form 4 ↗ |
| Mar 4, 2026 | Michal Nath Puri Chief Human Resources Officer | NVCR NovoCure Limited | Sale | 1,100 | $13.31 | $14.6K Sale | Form 4 ↗ |
| Mar 4, 2026 | Frank X. Leonard Chief Executive Officer | NVCR NovoCure Limited | Sale | 5,607 | $13.31 | $74.6K Sale | Form 4 ↗ |
| Mar 4, 2026 | Uri Weinberg Chf Medical and Innovation Ofr | NVCR NovoCure Limited | Sale | 6,412 | $13.31 | $85.3K Sale | Form 4 ↗ |
| Mar 3, 2026 | William F. Doyle Executive Chairman, Director | NVCR NovoCure Limited | Sale | 21,330 | $13.43 | $286.5K Sale | Form 4 ↗ |
| Mar 3, 2026 | William F. Doyle Executive Chairman, Director | NVCR NovoCure Limited | Sale | 50,557 | $12.79 | $646.6K Sale | Form 4 ↗ |
| Mar 2, 2026 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 408 | $13.49 | $5,504 Sale | Form 4 ↗ |
| Mar 2, 2026 | Frank X. Leonard Chief Executive Officer | NVCR NovoCure Limited | Sale | 7,232 | $13.49 | $97.6K Sale | Form 4 ↗ |
| Mar 2, 2026 | Uri Weinberg Chf Medical and Innovation Ofr | NVCR NovoCure Limited | Sale | 3,272 | $13.33 | $43.6K Sale | Form 4 ↗ |
| Feb 27, 2026 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 1,555 | $13.66 | $21.2K Sale | Form 4 ↗ |
| Feb 27, 2026 | Nicolas Leupin Former Chief Medical Officer | NVCR NovoCure Limited | Sale | 1,029 | $13.66 | $14.1K Sale | Form 4 ↗ |
| Feb 27, 2026 | Michal Nath Puri Chief Human Resources Officer | NVCR NovoCure Limited | Sale | 1,441 | $13.66 | $19.7K Sale | Form 4 ↗ |
| Feb 27, 2026 | Frank X. Leonard Chief Executive Officer | NVCR NovoCure Limited | Sale | 9,734 | $13.66 | $133.0K Sale | Form 4 ↗ |
| Feb 27, 2026 | Uri Weinberg Chf Medical and Innovation Ofr | NVCR NovoCure Limited | Sale | 7,461 | $13.84 | $103.3K Sale | Form 4 ↗ |
| Sep 5, 2025 | Ashley Cordova Chief Executive Officer | NVCR NovoCure Limited | Buy | 81,550 | $12.22 | $996.5K Buy | Form 4 ↗ |
| Jul 29, 2025 | Christoph Brackmann Chief Financial Officer | NVCR NovoCure Limited | Buy | 5,000 | $11.50 | $57.5K Buy | Form 4 ↗ |
| Jul 29, 2025 | Christoph Brackmann Chief Financial Officer | NVCR NovoCure Limited | Buy | 5,000 | $11.60 | $58.0K Buy | Form 4 ↗ |
| Jul 29, 2025 | Christoph Brackmann Chief Financial Officer | NVCR NovoCure Limited | Buy | 10,000 | $11.63 | $116.3K Buy | Form 4 ↗ |
| Jun 3, 2025 | Kristin Stafford Director | NVCR NovoCure Limited | Sale | 999 | $17.28 | $17.3K Sale | Form 4 ↗ |
| Jun 3, 2025 | Gabriel Leung Director | NVCR NovoCure Limited | Sale | 999 | $17.31 | $17.3K Sale | Form 4 ↗ |
| Jun 3, 2025 | Martin J. Madden Director | NVCR NovoCure Limited | Sale | 999 | $17.19 | $17.2K Sale | Form 4 ↗ |
| Jun 3, 2025 | Timothy J. Scannell Director | NVCR NovoCure Limited | Sale | 999 | $17.32 | $17.3K Sale | Form 4 ↗ |
| Jun 3, 2025 | Jeryl L. Hilleman Director | NVCR NovoCure Limited | Sale | 999 | $17.26 | $17.2K Sale | Form 4 ↗ |
| Jun 3, 2025 | Ocean Allyson J Director | NVCR NovoCure Limited | Sale | 999 | $17.29 | $17.3K Sale | Form 4 ↗ |
| Jun 3, 2025 | W. Anthony Vernon Director | NVCR NovoCure Limited | Sale | 999 | $17.35 | $17.3K Sale | Form 4 ↗ |
| Jun 3, 2025 | David Hung Director | NVCR NovoCure Limited | Sale | 999 | $17.30 | $17.3K Sale | Form 4 ↗ |
| Jun 2, 2025 | Frank X. Leonard EVP, Pres., Novocure Oncology | NVCR NovoCure Limited | Sale | 1,879 | $19.01 | $35.7K Sale | Form 4 ↗ |
| Jun 2, 2025 | Frank X. Leonard EVP, Pres., Novocure Oncology | NVCR NovoCure Limited | Sale | 6,600 | $17.99 | $118.7K Sale | Form 4 ↗ |
| Jun 2, 2025 | Frank X. Leonard EVP, Pres., Novocure Oncology | NVCR NovoCure Limited | Sale | 21,717 | $17.22 | $374.0K Sale | Form 4 ↗ |
| May 3, 2025 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 592 | $17.91 | $10.6K Sale | Form 4 ↗ |
| Mar 3, 2025 | Uri Weinberg Chief Innovation Officer | NVCR NovoCure Limited | Sale | 268 | $18.92 | $5,071 Sale | Form 4 ↗ |
| Mar 3, 2025 | Frank X. Leonard EVP, Pres., Novocure Oncology | NVCR NovoCure Limited | Sale | 2,527 | $18.54 | $46.9K Sale | Form 4 ↗ |
| Mar 3, 2025 | Ashley Cordova Chief Executive Officer | NVCR NovoCure Limited | Sale | 2,053 | $18.54 | $38.1K Sale | Form 4 ↗ |
| Mar 3, 2025 | Mukund Paravasthu Chief Operating Officer | NVCR NovoCure Limited | Sale | 250 | $18.54 | $4,635 Sale | Form 4 ↗ |
| Feb 28, 2025 | Uri Weinberg Chief Innovation Officer | NVCR NovoCure Limited | Sale | 311 | $18.31 | $5,694 Sale | Form 4/A ↗ |
| Feb 28, 2025 | Uri Weinberg Chief Innovation Officer | NVCR NovoCure Limited | Sale | 4,326 | $18.78 | $81.2K Sale | Form 4/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 8:26 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances